Advertising
Agriculture
Airlines-Aviation
Aerospace-Defense
Art
Auto
Banking-Financial Services
Beer, Wine & Spirits
Biometrics
Biotechnology
Books
Charity
Chemical
Computer Electronics
Computer Gaming
Computer Hardware
Computer Networks
Computer Software
Construction-Building
Consumer Electronics
Death Care Services
Education
Electronic Commerce
Electronic Components
Electronic Design Automation
Electronics Performance Measurement
Entertainment
Environmental Services
Fashion
Film-Motion-Picture
Food-Beverages
Gambling-Casinos
Government
Health Care-Hospitals
High-Tech Security
Higher Education
Homeland Security
Household-Consumer-Cosmetics
Infectious Disease Control
Insurance
Internet Technology
Legal
Leisure-Travel-Hotels
Machinery
Magazines
Maritime-Shipbuilding
Medical-Pharmaceuticals
Mining-Metals
Mobile Entertainment
Multimedia-Online-Internet
Music
Mutual Funds
Nanotechnology
Office Products
Oil-Energy
Otc-Smallcap
Paper-Forest-Products-Containers
Peripherals
Publishing-Information Services
Radio
Real Estate
Religion
Restaurants
Retail
Safety
Semiconductors
Sports
Supermarkets
Supplementary Medicine
Telecommunications
Television
Temporary Staffing Services
Textiles
Tobacco
Transportation-Trucking-Railroad
Travel
Utilities
Workforce Management/Human Resources
News Releases For November 3, 2009

Opportunity for Reconstructive Implants Tailored to Japanese Patients

Valeant Pharmaceuticals Highlights Taribavirin Phase IIb End of Study Data Presentation at American Association for the Study of Liver Disease (AASLD) Annual Meeting

Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75

Shorter Radiation Course as Effective as Standard Therapy For Prostate Cancer Recurrence

Fertili-Plus Introduces 5-Step Conception Framework

NCCN Guidelines for Kidney Cancer Updated to Include Pazopanib for Advanced Disease; Free Webinar Discusses Updates

AACE Issues New Medical Guidelines for Proper and Ethical Use of Growth Hormone

UCB Commemorates Epilepsy Awareness Month with New and Enhanced Patient-Centered Initiatives

Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update

Anthony Vuolo Appointed Chief Financial Officer of WebMD

PRA International Opens New Office in South Korea

Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group

Perrigo Company Divests Israel Cosmetics Business for 205 Million New Israeli Shekels

Medical Tourism Congress in Los Angeles a Huge Success

Inclinix Launches Redesigned Performance Enrollment Website

Caliper Life Sciences Expands LabChip(R) GX Product Capabilities, Broadens Application Focus, and Achieves Adoption Milestones

Cumberland Pharmaceuticals to Present at Lazard Healthcare Conference in New York on November 17, 2009

Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2009 Financial Results

PartsSource Wins Cascade Capital Award for Employee Growth

Objective Measures of ADHD Symptoms Using the Quotient(TM) ADHD System May Reduce Cost of ADHD Drug Trials

Proton Therapy is Well-Tolerated In Prostate Cancer Patients

Radiation After Surgery Reduces Chance of Melanoma Returning

Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C

FDA CONSUMER HEALTH INFORMATION UPDATES: Fraudulent H1N1 flu products, hearing aids, sound amplifiers, tobacco regulation, FDA's international posts, LASIK eye surgery, and FDA MedWatch safety alerts


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved.
A United Business Media company.